December 15, 2015—The White House Office of Management and Budget has finished reviewing the so-called Medicaid average manufacturer price (AMP) final rule, potentially clearing the way for its publication before the end of the year.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)